LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 3Symbiotec Pharmalab
03 1DKSH
04 1Capital Farma
05 1TAPI Technology & API Services
06 1Beijing Mesochem Technology
07 1ASG Biochem
08 1Aurisco Pharmaceutical
09 1Bayer AG
10 1CHEMO
11 1Cipla
12 1Curia
13 4Gedeon Richter
14 1Guangzhou Tosun Pharmaceutical
15 1Hangzhou Deli Chemical
16 2Industriale Chimica
17 1Lupin Ltd
18 2NEWCHEM SPA
19 1Nanjing Bold Chemical
20 1Qingdao Qingmei Biotech
21 1Sicor Societa Italiana Corticosteroidi Srl
22 1Sterling Spa
23 1Sun Pharmaceutical Industries Limited
24 1Swati Spentose
25 1Symbiotica Specialty Ingredients
26 1Teva Pharmaceutical Industries
27 1Zhejiang Xianju Junye Pharmaceutical Co. LTD
01 7China
02 1Germany
03 4Hungary
04 8India
05 2Israel
06 6Italy
07 1Malaysia
08 2Spain
09 1Switzerland
10 2U.S.A
01 10Active
02 24Blank
01 14Valid
02 1Withdrawn by Holder
03 19Blank
01 1303MF10024
02 1305MF10096
03 1305MF10112
04 1306MF10029
05 1306MF10044
06 29Blank
01 1WC-0161A2
02 2WC-0162A2
03 1WC-0168
04 30Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32885
Submission : 2018-08-30
Status : Active
Type : II
Certificate Number : CEP 2018-118 - Rev 01
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2404
Status : Valid
Date of Issue : 2022-09-30
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162A2
Address of the Firm :
Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 22878
Submission : 2009-06-18
Status : Active
Type : II
Available Reg Filing : ASMF |
Date of Issue : 2022-07-05
Valid Till : 2025-07-02
Written Confirmation Number : WC-0161A2
Address of the Firm :
Date of Issue : 2022-08-31
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162A2
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23580
Submission : 2010-08-16
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17866
Submission : 2004-12-03
Status : Active
Type : II
Certificate Number : R1-CEP 2009-402 - Rev 00
Issue Date : 2015-06-08
Type : Chemical and TSE
Substance Number : 2404
Status : Valid
Registration Number : 305MF10112
Registrant's Address : BUDAPEST, GYOMROI UT 19-21, HUNGARY
Initial Date of Registration : 2023-09-26
Latest Date of Registration : --
A Drospirenone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Drospirenone, including repackagers and relabelers. The FDA regulates Drospirenone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Drospirenone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Drospirenone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Drospirenone supplier is an individual or a company that provides Drospirenone active pharmaceutical ingredient (API) or Drospirenone finished formulations upon request. The Drospirenone suppliers may include Drospirenone API manufacturers, exporters, distributors and traders.
click here to find a list of Drospirenone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 27 companies offering Drospirenone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?